Page 5 - Biomed Media Contact News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomed media contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomed Media Contact Today - Breaking & Trending Today

Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment

Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment
Strontium89 Now Reimbursed in All Treatment Settings
News provided by
Share this article
NEW YORK, Jan. 7, 2021 /PRNewswire/
Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that the Centers for Medicare and Medicaid Services (CMS) updated the Outpatient Prospective Payment System (OPPS) reimbursement rate for its FDA approved non-opioid metastatic bone pain drug
Strontium89 (Strontium Chloride Sr-89 Injection, USP) on January 3, 2021. The update ensures all Medicare patients have access to Strontium89 in the appropriate setting.
The Q1 2021 Strontium89 reimbursement update was expected by Q BioMed as part of the standard CMS quarterly OPPS update, and is an important milestone. While Strontium89 has been appropriately reimbursed in the free standing clinic setting since launch, it was under-reimbursed in the hospital ....

Denis Corin , Keith Pinder , Centers For Medicare , Securities Exchange , Cq Biomed Inc , Medicaid Services , Sourceq Biomed Inc , Isotherapeutics Group , Outpatient Prospective Payment System , Strontium Chloride , Important Safety Information , Abiomed Inc , Looking Statements , Securities Act , Securities Exchange Act , Biomed Media Contact , டெனிஸ் கோரின் , கேய்ட் பைண்டர் , மையங்கள் க்கு மருத்துவ , பத்திரங்கள் பரிமாற்றம் , க்யூ பயோமெட் இன்க் , மருத்துவ உதவி சேவைகள் , ஔட்‌ப்யாஶஂட் ப்ரோஸ்பெக்டிவ் கட்டணம் அமைப்பு , ஸ்ட்ரோண்டியம் குளோரைடு , முக்கியமான பாதுகாப்பு தகவல் , பயோமெட் இன்க் ,

Q BioMed Updates Shareholders at Year End

Q BioMed Updates Shareholders at Year End
Company Expects Several Milestones as Momentum Builds for 2021
News provided by
Share this article
Dear Fellow Shareholders,
As 2020 draws to a close, we join the rest of the world in looking forward to a new year with new beginnings and hope for a quick return to whatever the new normal will be. Leaving behind the constant threat of lockdowns and the interruption the COVID-19 pandemic has had on our lives will be a welcome change.
With that in mind we acknowledge that 2020 was not the year we promised and feel even more committed to achieving our stated goals. We learned a great deal about Q BioMed s place in the fragile world in which we live and operate. With the 20/20 view of hindsight, we are excited about the coming year. ....

United States , Denis Corin , Keith Pinder , Us Department Of Defense , Ragiv Ghandi Center , Mannin Research Inc , Product Development , Oklahoma Medical Research Foundation , Mcmaster University , Cq Biomed Inc , Sourceq Biomed Inc , Chemveda Life Sciences , Securities Exchange , Us Department Of Veteran Affairs , American Society Of Therapeutic Radiation Oncology , Washington University In St , Oncology Nursing Society , Fellow Shareholders , Palliative Treatment , Metastatic Bone Cancer , Veteran Affairs , American Society , Therapeutic Radiation Oncology , Acute Respiratory Distress Syndrome , Investigational New Drug , Clinical Trial ,